These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8769216)
21. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients. Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302 [No Abstract] [Full Text] [Related]
22. Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group. Peeters P; Kazek M; Abella I; Noble I Transplant Proc; 1998 Aug; 30(5):1838-42. PubMed ID: 9723301 [No Abstract] [Full Text] [Related]
24. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption. Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210 [No Abstract] [Full Text] [Related]
25. Follow-up after conversion to Neoral in stable heart transplant recipients. Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226 [No Abstract] [Full Text] [Related]
26. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients. Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299 [TBL] [Abstract][Full Text] [Related]
27. An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients. Park K; Koh YB; Kwak JY; Kim SJ; Yoon YS; Kang CM; Kim YS Transplant Proc; 1996 Jun; 28(3):1202-3. PubMed ID: 8658627 [No Abstract] [Full Text] [Related]
28. An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral. Pasha TM; Wiesner RH; Dahlke LM; Porayko MK; Krom RA Liver Transpl Surg; 1998 Sep; 4(5):410-5. PubMed ID: 9724479 [TBL] [Abstract][Full Text] [Related]
29. Changing stable heart transplant recipients from Sandimmune to Neoral. Dalrymple-Hay M; Meara M; Reynolds L; Backhouse L; Wright D; Holt D; Johnston A; Madden B; Murday A Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227 [No Abstract] [Full Text] [Related]
30. Case reports on conversion to Neoral therapy in renal transplant patients. Curtis JJ Transplant Proc; 1996 Aug; 28(4):2221-2; discussion 2218. PubMed ID: 8769205 [No Abstract] [Full Text] [Related]
31. Potential role of Neoral in pediatric liver transplantation. Whitington PF; Alonso EM; Millis JM Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221 [No Abstract] [Full Text] [Related]
32. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Cao S; Cox KL; Berquist W; So S; Concepcion W; Monge H; Esquivel CO Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373 [No Abstract] [Full Text] [Related]
33. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214 [No Abstract] [Full Text] [Related]
34. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. White M; Pelletier GB; Tan A; Jesina C; Carrier M J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770 [TBL] [Abstract][Full Text] [Related]